Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioAtla, Inc. Director's Dealing 2023

Dec 19, 2023

34681_dirs_2023-12-19_0da575fd-be07-4ba9-b14f-002f2f1528e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2023-12-19

Reporting Person: Vasquez Christian (See Remarks)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-19 Common Stock P 7495 $2.0363 Acquired 115659 Direct

Footnotes

F1: The range of prices for the shares of Common Stock is from $2.02 to $2.04. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

F2: Includes shares purchased under the Issuer's ESPP Plan.